Items where authors include "Bishop, R.T."
Article
Marino, S., Hannemann, N., Bishop, R.T. et al. (12 more authors) (2022) Anti-inflammatory, but not osteoprotective, effect of the TRAF6/CD40 inhibitor 6877002 in rodent models of local and systemic osteolysis. Biochemical Pharmacology, 195. 114869. ISSN 0006-2952
Marino, S., Bishop, R.T., Carrasco, G. et al. (3 more authors) (2019) Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo. Calcified Tissue International, 105 (2). pp. 193-204. ISSN 0171-967X
Marino, S., de Ridder, D., Bishop, R.T. et al. (14 more authors) (2019) Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice. EBioMedicine, 44. pp. 452-466. ISSN 2352-3964
Bishop, R.T., Marino, S., de Ridder, D. et al. (6 more authors) (2019) Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer. Cancer Letters, 450. pp. 76-87. ISSN 0304-3835
Marino, S., Bishop, R.T., Mollat, P. et al. (1 more author) (2018) Pharmacological inhibition of the skeletal IKKβ reduces breast cancer-induced osteolysis. Calcified Tissue International, 103 (2). pp. 206-216. ISSN 0171-967X
de Ridder, D., Marino, S., Bishop, R.T. et al. (4 more authors) (2018) Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A. Scientific Reports , 8. 6877. ISSN 2045-2322
Marino, S., Bishop, R.T., Capulli, M. et al. (9 more authors) (2018) Regulation of breast cancer induced bone disease by cancer-specific IKKβ. Oncotarget, 9 (22). pp. 16134-16148. ISSN 1949-2553
Peramuhendige, P., Marino, S., Bishop, R.T. et al. (6 more authors) (2018) TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. Scientific Reports, 8. 39. ISSN 2045-2322
Marino, S., Bishop, R.T., Logan, J.G. et al. (2 more authors) (2017) Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis. Cancer Letters, 410. pp. 180-190. ISSN 0304-3835